Bachem (OTCMKTS:BCHMF) Trading Up 12.3% – What’s Next?

Bachem Holding AG (OTCMKTS:BCHMF)’s share price shot up 12.3% during trading on Thursday . The stock traded as high as $86.11 and last traded at $86.11. 100 shares were traded during trading, an increase of 0% from the average session volume of 100 shares. The stock had previously closed at $76.65.

Analysts Set New Price Targets

Separately, Royal Bank Of Canada restated an “outperform” rating on shares of Bachem in a report on Monday, January 26th. Three equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Bachem currently has a consensus rating of “Moderate Buy”.

Bachem Trading Up 12.3%

The stock’s 50 day simple moving average is $80.03 and its two-hundred day simple moving average is $70.45.

About Bachem

Bachem Holding AG is a Switzerland‐based specialty biochemical company focused on the development, manufacturing and commercialization of peptides and oligonucleotides. Serving pharmaceutical and biotechnology clients as well as academic research institutions, the company offers a broad spectrum of products ranging from custom peptide synthesis for research applications to clinical and commercial‐grade active pharmaceutical ingredients (APIs). Bachem’s expertise extends to process development, scale‐up and GMP‐compliant production, supporting projects in therapeutic areas such as oncology, metabolic disorders and infectious diseases.

Founded in 1971 and headquartered in Bubendorf, Switzerland, Bachem has grown through strategic investments in production capacity and the acquisition of complementary peptide and oligonucleotide technologies.